Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2389060-50-6
2. Linvemastat [inn]
3. Fp2amm4svf
4. Schembl21577957
5. Bdbm475517
6. Ex-a13612
7. Us10851089, Compound Fc-4
8. Us10851089, Compound Fc-30
9. Us10851089, Compound Fc-31
10. 2,4-imidazolidinedione, 5-[3-[[4-[(2-methyl-4-pyridinyl)methoxy]phenyl]thio]-2-furanyl]-
11. 5-[3-[[4-[(2-methyl-4-pyridinyl)methoxy]phenyl]thio]-2-furanyl]-2,4-imidazolidinedione
12. Rac-(14r)-72-methyl-5-oxa-3-thia-7(4)-pyridina-1(4)-imidazolidina-2(2,3)-furana-4(1,4)-benzenaheptaphane-12,15-dione
| Molecular Weight | 395.4 g/mol |
|---|---|
| Molecular Formula | C20H17N3O4S |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 119 |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 570 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
66
PharmaCompass offers a list of Linvemastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Linvemastat manufacturer or Linvemastat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linvemastat manufacturer or Linvemastat supplier.
A Linvemastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linvemastat, including repackagers and relabelers. The FDA regulates Linvemastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linvemastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Linvemastat supplier is an individual or a company that provides Linvemastat active pharmaceutical ingredient (API) or Linvemastat finished formulations upon request. The Linvemastat suppliers may include Linvemastat API manufacturers, exporters, distributors and traders.
Linvemastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Linvemastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Linvemastat GMP manufacturer or Linvemastat GMP API supplier for your needs.
A Linvemastat CoA (Certificate of Analysis) is a formal document that attests to Linvemastat's compliance with Linvemastat specifications and serves as a tool for batch-level quality control.
Linvemastat CoA mostly includes findings from lab analyses of a specific batch. For each Linvemastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Linvemastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Linvemastat EP), Linvemastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Linvemastat USP).
